Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2023	$ 855,808	$ 839,320	$ 10	$ 230,291,834	$ (78,779)	$ (224,627,386)	$ 7,280,807
Balance, shares at Dec. 31, 2023	85,581	1,688	96,375
Net loss						(2,853,806)	(2,853,806)
Other comprehensive income (loss)					87,979		87,979
Stock-based compensation expense				705,770			705,770
Warrant exercises, net			$ 1	2,300,688			2,300,689
Warrant exercises, net, shares			13,088
Balance at Mar. 31, 2024	$ 855,808	$ 839,320	$ 11	233,298,292	9,200	(227,481,192)	7,521,439
Balance, shares at Mar. 31, 2024	85,581	1,688	109,463
Balance at Dec. 31, 2023	$ 855,808	$ 839,320	$ 10	230,291,834	(78,779)	(224,627,386)	7,280,807
Balance, shares at Dec. 31, 2023	85,581	1,688	96,375
Net loss							(6,779,018)
Other comprehensive income (loss)							24,957
Balance at Jun. 30, 2024	$ 855,808	$ 839,320	$ 11	233,326,917	(53,822)	(231,406,404)	3,561,830
Balance, shares at Jun. 30, 2024	85,581	1,688	115,983
Balance at Mar. 31, 2024	$ 855,808	$ 839,320	$ 11	233,298,292	9,200	(227,481,192)	7,521,439
Balance, shares at Mar. 31, 2024	85,581	1,688	109,463
Net loss						(3,925,212)	(3,925,212)
Other comprehensive income (loss)					(63,022)		(63,022)
Stock-based compensation expense				28,625			28,625
Issuance of shares in abeyance
Issuance of shares in abeyance, shares			6,520
Balance at Jun. 30, 2024	$ 855,808	$ 839,320	$ 11	233,326,917	(53,822)	(231,406,404)	3,561,830
Balance, shares at Jun. 30, 2024	85,581	1,688	115,983
Balance at Dec. 31, 2024	$ 855,808	$ 839,320	$ 14	234,252,981	8,345	(237,819,806)	(1,863,338)
Balance, shares at Dec. 31, 2024	85,581	1,688	139,168
Net loss						(6,105,887)	(6,105,887)
Stock-based compensation expense				20,783			20,783
Issuance of restricted stock units
Issuance of restricted stock units, shares			1,000
Issuance of common stock and pre-funded warrants, net			$ 55	2,086,537			2,086,592
Issuance of common stock and pre-funded warrants, shares			553,846
Issuance of common stock in connection with stock split			$ 6	(6)
Issuance of common stock in connection with stock split, shares			60,860
Conversion of 2025 Series B warrants into common stock			$ 884	9,757,029			9,757,913
Conversion of 2025 Series B warrants into common stock, shares			8,834,034
Balance at Mar. 31, 2025	$ 855,808	$ 839,320	$ 959	246,117,324	8,345	(243,925,693)	3,896,063
Balance, shares at Mar. 31, 2025	85,581	1,688	9,588,908
Balance at Dec. 31, 2024	$ 855,808	$ 839,320	$ 14	234,252,981	8,345	(237,819,806)	(1,863,338)
Balance, shares at Dec. 31, 2024	85,581	1,688	139,168
Net loss							(7,148,459)
Other comprehensive income (loss)
Balance at Jun. 30, 2025	$ 855,808	$ 839,320	$ 1,162	247,060,568	8,345	(244,968,265)	3,796,938
Balance, shares at Jun. 30, 2025	85,581	1,688	11,620,317
Balance at Mar. 31, 2025	$ 855,808	$ 839,320	$ 959	246,117,324	8,345	(243,925,693)	3,896,063
Balance, shares at Mar. 31, 2025	85,581	1,688	9,588,908
Net loss						(1,042,572)	(1,042,572)
Other comprehensive income (loss)
Conversion of 2025 Series B warrants into common stock			$ 134	672,684			672,818
Conversion of 2025 Series B warrants into common stock, shares			1,339,368
Issuance of common stock in connection with license agreement			$ 69	270,560			270,629
Balance at Jun. 30, 2025	$ 855,808	$ 839,320	$ 1,162	$ 247,060,568	$ 8,345	$ (244,968,265)	$ 3,796,938
Balance, shares at Jun. 30, 2025	85,581	1,688	11,620,317